Apo-Sertraline (2017-01-13)

Starting date:
January 13, 2017
Posting date:
January 16, 2017
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-61808

Reason

Affected Lot (Apo-Sertraline 50 mg) may contain units of sertraline 25 mg.

Depth of distribution

Wholesalers and Retailers - Canada (AB, BC, MB, NB, NF, NS, ON, QC, and SK)

Affected products

Apo-Sertraline

DIN, NPN, DIN-HIM

DIN 02238281

Dosage form

Capsule

Strength

50 mg Sertraline (Sertraline Hydrochloride)

Lot or serial number

MV1007

Companies

Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA